Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin‐Induced Sporadic Alzheimer’s Disease in Mice

1 Jan 2021

Abstract excerpt

Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairment. Gut microbiota dysfunction (dysbiosis) is implicated in the pathology of AD and is associated with several detrimental consequences, including neurotransmitter depletion, oxidative stress, inflammation, apoptosis, and insulin resistance, which all contribute to the onset of AD. The objective of this study was to assess...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Gut microbiota and health
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34306309
DOI: 10.1155/2021/5525306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin‐Induced Sporadic Alzheimer’s Disease in MicePMID 34306309Read ↗

Kefir metabolites in a fly model for Alzheimer’s diseaseSemantic proximity Read ↗

The Microbiome and Alzheimer’s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic FormulationsSemantic proximity Read ↗

Association Between the Gut Microbiota and Alzheimer’s Disease: An Update on Signaling Pathways and Translational TherapeuticsSemantic proximity Read ↗

Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical ModelsSemantic proximity Read ↗

Identification of bioactive peptides from a Brazilian kefir sample, and their anti-Alzheimer potential in Drosophila melanogasterSemantic proximity Read ↗

The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to TreatmentSemantic proximity Read ↗

Dietary Pattern, Gut Microbiota, and Alzheimer’s DiseaseSemantic proximity Read ↗

Next Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic PerspectiveSemantic proximity Read ↗

Multi-strain probiotics ameliorate Alzheimer’s-like cognitive impairment and pathological changes through the AKT/GSK-3β pathway in senescence-accelerated mouse prone 8 miceSemantic proximity Read ↗

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer’s DiseaseSemantic proximity Read ↗

Probiotics as potential therapeutic options for Alzheimer’s diseaseSemantic proximity Read ↗

Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.